Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Stroke. 2013 May 23;44(7):10.1161/STROKEAHA.111.000485. doi: 10.1161/STROKEAHA.111.000485

Table 1.

Baseline Characteristics of the Population by Case-Control Status in 1990

Cases (n=461) Controls (n=461) p-value
Age (years) 61 ± 6.0 61 ± 6.0 0.93
DHEAS (μg/dL) 76.7 ± 60.7
(median=58.7)
79.9 ± 57.2
(median=66.0)
0.10
White, % 97 98 0.37
BMI (kg/m2) 26.0 ± 5.1 25.4 ± 4.8 0.10
Smoking, % 0.84
 Never 42 42
 Past 40 42
 Current 18 16
Postmenopausal Hormone Therapy Use 0.99
 Premenopausal/Dubious 11 11
 Postmenopausal, Non-hormone therapy users 47 47
 Postmenopausal, Hormone therapy users 42 42
Alcohol (g/day) 5.9 ± 10.8 5.3 ± 10.2 0.48
Physical Activity (METs/week) 15.2 ± 19.8 16.2 ± 18.5 0.15
Hypertension, % 48 34 <0.0001
High Cholesterol, % 48 46 0.64
History of Heart Disease, % 5 6 0.55
Family History of Heart Disease, % 12 7 0.01
Diabetes, % 13 6 0.0007
HbA1c≥6, % 17 11 0.01
CRP≥3 (mg/L) 40 34 0.08
Year of Blood Draw 1990 ± 0.33 1990 ± 0.33 0.51

Values are means ± SD (except where noted) or percentages

t-test, Wilcoxon rank-sum test or Chi-square test used as appropriate